Ticker Details
Medicinova Inc MediciNova Inc is a biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.
IPO Date:	December 7, 2006
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$63.99M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.14 | 3.06%
Avg Daily Range (30 D):	$0.02 | 1.46%
Avg Daily Range (90 D):	$0.04 | 2.46%

Institutional Daily Volume
Avg Daily Volume:	.12M
Avg Daily Volume (30 D):	.02M
Avg Daily Volume (90 D):	.04M

Trade Size
Avg Trade Size (Sh.):	177
Avg Trade Size (Sh.) (30 D):	208
Avg Trade Size (Sh.) (90 D):	173

Institutional Trades
Total Institutional Trades:	59
Avg Institutional Trade:	$1.84M
Avg Institutional Trade (30 D):	$.57M
Avg Institutional Trade (90 D):	$.55M
Avg Institutional Trade Volume:	.29M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.19M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	538.88K

News

Jun 8, 2026 @ 5:00 PM Alcohol Use Disorder Market Set to Expand at a 12.... Source: Delveinsight

May 26, 2026 @ 11:00 PM MediciNova Announces Completion of Last Patient La... Source: Medicinova, Inc.

Apr 27, 2026 @ 11:00 PM New Peer‑Reviewed Study Reveals Actionable ... Source: Medicinova, Inc.

Mar 16, 2026 @ 11:00 AM MediciNova to Participate at the 38th Annual ROTH ... Source: Medicinova, Inc.

Jan 29, 2026 @ 11:00 PM MediciNova Announces 100 Patients Enrolled in SEAN... Source: Medicinova, Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.23	$-.05	$-.05
Diluted EPS	$-.23	$-.05	$-.05
Revenue	$.6M	$.19M	$.15M
Gross Profit
Net Income / Loss	$-11.72M	$-2.59M	$-2.8M
Operating Income / Loss	$-12.92M	$-2.84M	$-3.09M
Cost of Revenue
Net Cash Flow	$-5.79M	$M	$-9.57M
PE Ratio

Splits
Oct 31, 2006	1:10